ABSTRACT. Acute hypoxic pulmonary vasoconstriction PVR, pulmonary vascular resistance is attenuated by respiratory alkalosis. It is unknown if SVR, systemic vascular resistance alkalosis similarly reduces pulmonary vasoconstriction HR, heart rate produced by thromboxane A2. Respiratory alkalosis does Paw, peak proximal airway pressure not always attenuate persistent pulmonary hypertension in Pvoz, mixed venous oxygen tension newborns, some of whom have elevated serum thromboxane B2 levels. We hypothesized that alkalosis attenuates thromboxane-induced ~ulmonary vasoconstriction less than it does hypoxic vasoconstriction in infants. Hemodynamic responses to respiratory alkalosis during pulmonary vasoconstriction produced in random order by breathing 12% inspired oxygen and by infusing 0.1 j.~g/kg/ min of the thromboxane-mimetic U46,619 were compared in eight 2-wk-old piglets. Hypoxia increased mean pulmonary artery pressure from 12 f 3 to 29 f 2 mm Hg and pulmonary vascular resistance (PVR) from 11 f 4 to 25 f 8 mmHg/L/min; U46,619 increased pulmonary artery pressure from 16 +. 5 to 37 f 6 mm Hg and PVR from 14 f 5 to 51 f 17 mm Hg/liter/min. U46,619 also decreased cardiac output accounting in part for the greater increase in PVR compared to hypoxia-induced vasoconstriction. Respiratory alkalosis decreased PVR to 14 f 6 mm Hg/ literlmin during exposure to hypoxia and to 28 f 9 mm Hg/liter/min during infusion of U46,619. In six additional piglets with U46,619-induced pulmonary vasoconstriction, the effects of lung stretch and hypocapnic alkalosis were separated by doubling tidal volume and then adding inspired COz to return PaC02 to prehyperventilation levels. Respiratory alkalosis decreased PVR from 52 f 36 to 35 2 21 mm Hg/liter/min. Despite the increased tidal volume, PVR increased to 53 f 35 Hg/liter/min when PaCOz returned to 44 f 5 mm Hg. Respiratory alkalosis rather than lung stretch reduces thromboxane-induced and hypoxia-induced pulmonary vasoconstriction by equal proportions. (Pediatr Res 24: 558-562, 1988) Abbreviations CO, cardiac output HPV, hypoxic pulmonary vasoconstriction Acute HPV in both adult and young animals is attenuated by respiratory and metabolic alkalosis (1-4). Although alveolar hypoxia is not necessarily the cause of idiopathic PPHN, clinicians hyperventilate infants with PPHN to produce respiratory alkalosis in an attempt to selectively reduce PVR, increase pulmonary blood flow, and improve arterial oxygenation by reducing rightto-left shunting of venous blood through the ductus arteriosus and foramen ovale (5, 6). Despite ventilation with 1.0 F I O~ and hyperventilation, pulmonary hypertension does not fall below systemic levels in some of these infants, leading to a mortality of 17% or more (7) (8) (9) . This experience has prompted a search for endogenous vasoactive substances which increase PVR in the absence of alveolar hypoxia, any of which may play a pathogenic role in some infants with PPHN. Hammerman, et al. (10) have reported increased serum levels of thromboxane B2, the stable metabolite of the pulmonary vasoconstrictor thromboxane A2, in some infants with PPHN. Stenmark et al. (1 1) have measured elevated levels of vasoconstrictor leukotrienes C4 and D4 in the bronchial washings of infants with PPHN. The effect of respiratory alkalosis on pulmonary hypertension produced by circulating endogenous vasoconstrictors is unknown. We hypothesized that respiratory alkalosis produced by hyperventilation would attenuate pulmonary vasoconstriction produced by a mimetic of thromboxane A2 less than hypoxia-induced pulmonary vasoconstriction in infants. We subsequently examined if increased tidal volume associated with respirator-induced hyperventilation reduced thromboxane-induced pulmonary hypertension independent of hypocapnic alkalosis.
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MATERIALS AND METHODS
Pew, end-ex~irator~ pulmonary capillary wedge Pressure Animal preparation. Fourteen piglets, 16 f 5 days and 3.5 k Ppa, mean pulmonary artery pressure 0.4 kg (mean f SD), were anesthetized with 45 mg/kg intrave-PPHN, persistent pulmonary hypertension of the newborn nous pentobarbital, heparinized, and mechanically ventilated via Psa, mean systemic artery pressure a tracheostomy tube at a tidal volume of 12 + 2 ml/kg and a rate which maintained Pacol of 40 k 3 mm Hg at the onset of Blood gas tensions, pH, and inspired gas composition were determined using a Corning 168 pH/blood gas analyzer (Corning Medical, Medfield, MA). PVR was calculated from the formula, PVR = Ppa -Pcw/CO; SVR was estimated from the formula,
U46,619 preparation. The thromboxane mimetic, U46,6 19, which is 9,ll ,dideoxy-1 la,9a epoxymethano-prostaglandin F2a (Upjohn Pharmaceutical Company, Kalamazoo, MI), was supplied as 1 mg/ml in methylacetate. Aliquots of 100 pg were removed, dried, and resuspended in 95% ethanol and stored at -20°C. Before each experiment, an aliquot was removed, thawed, and combined in a variable amount of normal saline to a final ethanol concentration of 0.03-0.05%. This solution was administered at 0.15 ml/min to deliver a dose of 0.075-0.15 pg/ kg/min.
Experimental design Experiment 1: Comparison of Effects of Hyperventilation on Alveolar Hypoxia and U46,619-induced Pulmonary Vasoconstriction.
Eight piglets were studied to determine the relative effect of respiratory alkalosis upon both hypoxic and U46,6 19-induced pulmonary vasoconstriction. Initial hemodynamic measurements were made after ventilating animals with 0.26 F102 when hemodynamic indices had been stable for 15 min. Animals then received either alveolar hypoxia or U46,619 first and, after recovery, received the alternative vasoconstrictive stimulus. The hypoxic challenge was created by ventilating animals with 0.12 F102 and measuring hemodynamic and blood gas indices 20 rnin after the onset of hypoxia. Animals were then hyperventilated by increasing both tidal volume and ventilator rate for an additional 20 rnin of continued hypoxia before hemodynamic and blood gas measurements were repeated. During hyperventilation, the inspired oxygen concentration was adjusted to maintain the same end-tidal and therefore arterial oxygen tension that existed before hyperventilation. The alternative vasoconstrictive challenge included infusion of 0.075-0.15 pg/kg/min of U46,6 19 while the animals were ventilated with 0.26 Fro2. Supplemental oxygen was used to avoid the confounding effects of hypoxic pulmonary vasoconstriction based upon preliminary experience that U46,619 in piglets breathing room air reduced Pao2 from 79 +. 5 to 62 + 6 mm Hg ( n = 4). The chosen dose of U46,619 doubled mean pulmonary artery pressure in the absence of hypoxic pulmonary vasoconstriction.
Hemodynamic and blood gas indices were measured 20 min after the onset of the infusion when Paco, was normal and 20 rnin after the onset of hyperventilation. A recovery period of 30 rnin occurred between challenges with vasoconstrictive stimuli and the second challenge was not initiated until hemodynamic measurements and blood gas tensions returned to prechallenge values. At the conclusion of the experiment, each animal was sacrificed with an overdose of pentobarbital.
Experiment 2: Effect of Lung Stretch and Respiratory Alkalosis on U46,619-induced Pulmonary Vasoconstriction. Six additional piglets of the same weight and postnatal age ventilated with 0.26 F102 were studied while receiving 0.1 f 0.03 pg/kg/min of U46, 6 19 . The relative effects of increasing lung distension with increased tidal volume and of reducing Paco2 were separated by adding C 0 2 to the inspired gas while doubling tidal volume. Piglets were randomized to receive either increased tidal volume followed 20 rnin later by addition of C 0 2 or alternatively increased tidal volume with increased inspired COz followed 20 min later by discontinuation of supplemental inspired CO* and continued hyperventilation. Hemodynamic indices and blood gas tensions were measured before and 20 rnin after the onset of U46,6 19 administration during normal ventilation, 20 min after the onset of hyperventilation with or without supplemental FICOI, and 40 min after the onset of hyperventilation with the alternative option of supplemental CO2 as described above. Supplemental F I C O~ (3.5 k 0.4%) was delivered in a quantity that returned Pacoz to prehyperventilation values.
Data analysis. Hemodynamic and blood gas measurements were compared in the first experiment using a one-way analysis of variance (Minitab Release 82.1, Pennsylvania State University, 1984) and unpaired Student's t tests using a Bonferroni correction factor to account for multiple comparisons (14) to discern significant differences between conditions before and after initiation of a vasoconstrictive stimulus and between conditions of vasoconstriction and subsequent respiratory alkalosis. The percent change in hemodynamic values in response to alkalosis during hypoxia and during infusion of U46, 6 19 was compared using a paired Student's t test. The one-way analysis of variance and unpaired Student's t tests were also used to compare data measured among conditions of U46,6 19-induced vasoconstriction with and without hyperventilation with and without supplemental inspired C02. A p value of €0.02 was considered statistically significant.
RESULTS
Experiment I. Hemodynamic and respiratory gas exchange values for eight piglets before and after respiratory alkalosis was superimposed upon hypoxic pulmonary vasoconstriction and upon U46,619-induced pulmonary vasoconstriction are presented in Table 1 . Individual responses in CO and Ppa are illustrated in Figure 1 to demonstrate consistent responses of variable magnitude that occurred among animals with variable baseline values of Ppa, CO, and PVR.
By design, Ppa increased by a similar proportion, 237 f 46% versus 257 f 82%, when vasoconstriction was produced by 12% inspired oxygen or by infusion of 0.1 pg/kg/min of U46,619. This was accompanied by a variable change in cardiac output among animals exposed to hypoxia which did not significantly differ compared to the mean baseline normoxic values of the group (Fig. 1) . In contrast, U46,6 19 consistently reduced cardiac output compared to preinfusion values in every animal. HR increased in every animal from 167 f 24 to 209 f 44 beats/min in response to hypoxia but did not change consistently (183 f 23 versus 179 k 19 beats/min) during infusion of U46,619. Pulmonary capillary wedge pressure did not change significantly during the hypoxic exposure or infusion of U46,619. The net result was a statistically greater increase in PVR among animals during U46, 6 19 infusion (395 +-180%) than during exposure to alveolar hypoxia (229 f 74%) (p < 0.05). During both conditions of pulmonary vasoconstriction, Paco2, pH, and SVR did not change. As expected, Pa02 fell significantly in response to alveolar hypoxia but not when animals were ventilated with 26% F102 before and during the infusion of U46,6 19. Pvo2 fell as expected Table I for statistical analysis of data for each experimental condition. during exposure to 12% F102 but also decreased significantly after the onset of U46,6 19 in association with the decreased CO.
Respiratory alkalosis during exposure to hypoxia and during infusion of U46,619 were produced by increasing both tidal volume and ventilator rate as depicted in Table 2 . The increase in minute ventilation and Paw were similar during the hypoxic exposure and infusion of U46,6 19. Consequently, increased minute ventilation reduced Paco2 and increased arterial pH equally during both conditions of pulmonary vasoconstriction (Table 1) .
Respiratory alkalosis reduced Ppa by equal proportions (53 + 12% versus 60 + 10%) compared to values measured during normocarbic vasoconstriction produced by hypoxia and U46,619. However, respiratory alkalosis did not return Ppa to preinfusion levels during administration of U46,6 19. Hyperventilation did not significantly influence cardiac output in animals receiving hypoxia or U46,619 (Fig. I) . More specifically, the decreased CO in response to U46,6 19 was not consistently improved by respiratory alkalosis despite a consistent increase HR from 179 k 19 to 209 + 35 beatslmin and a reduction in Ppa (Fig. 1) . Respiratory alkalosis reduced PVR by equal proportions (54 +-14% versus 55 + 6%) under conditions of pulmonary vasoconstriction produced by hypoxia and U46,619 (Table 1) . Experiment 2. Table 3 displays the effects of U46,6 19 infusion before and after hypocapnic and normocarbic mechanical overventilation with twice the baseline minute volume. As in the first experiment, U46,6 19 increased pulmonary artery pressure and PVR significantly. During hyperventilation as depicted in Table   2 , Paco2 fell to 23 + 4 mm Hg, and pH rose to 7.61 + 0.06 (Table 2) . Lung stretch was reflected by the significant increase in tidal volume and Paw (Table 2) . Paw, tidal volume, and minute volume did not change when COz was added to the inspired gas. Respiratory alkalosis associated with increased minute volume, as in experiment 1, reduced Ppa to 64 + 11 % and PVR to 63 +-9% of prehyperventilation values, respectively; CO did not change in response to hyperventilation. Respiratory alkalosis did not return Ppa or PVR to preinfusion values during administration of U46,619. Ventilation with twice the minute volume containing supplemental CO* returned Pacoz, pH, Ppa, and PVR to prehyperventilation normocarbic levels during infusion of U46,6 19.
DISCUSSION
The results of this study demonstrate that respiratory alkalosis produced by doubling minute ventilation reduces pulmonary vasoconstriction produced by alveolar hypoxia and intravenous U46,619 by equal proportions in young piglets. However, in contrast to the effects of alkalosis on HPV, the reduction in Ppa and PVR during infusion with U46,619 does not return these indices to preinfusion values. Furthermore, the reduction in PVR during infusion of U46,619 occurs in response to respiratory alkalosis rather than lung stretch per se. These results suggest that pulmonary hypertension produced by elevated thromboxane synthesis in young animals and perhaps human newborns with otherwise normal pulmonary vascular anatomy should be only partially attenuated by respiratory alkalosis.
In contrast to changes in pulmonary artery pressure, respiratory alkalosis did not alter the reduction in CO produced by the thromboxane mimetic U46,619. Presuming the distribution of CO and metabolic rate remained unchanged, the decreased Pv02 during infusion of U46,619 suggests a small but significant increase in oxygen extraction in response to decreased peripheral perfusion despite respiratory alkalosis. Barbiturate anesthesia may have contributed to the reduction in CO during the U46, 6 19 infusion, but recovery of CO to preinfusion levels 30 min after discontinuation of U46, 6 19 suggests that this potential drug interaction was not sustained. U46,6 19 reduced CO but did not change HR, suggesting that the drug primarily reduced stroke volume. The results are consistent with previous work suggesting that thromboxane A2 produced coronary vasospasm independent of pulmonary vasoconstriction which may adversely affect cardiac performance (1 5, 16) .
Alternative pharmacologic interventions to treat thromboxane-induced pulmonary hypertension in infants have been described using the piglet model of group B streptococcal sepsis. In seven previous reports, intravenous group B streptococci produced a common hemodynamic response which included an increase in Ppa of 260-350% of baseline values, a reduction in CO by 30-60%, and an increase in PVR of 420-775% (17) (18) (19) (20) (21) (22) (23) . Each of these reports has investigated a pharmacologic intervention that might improve hemodynamic function in septic infant animals. Intravenous epinephrine, indomethacin, dazmegrel, and the leukotriene receptor antagonist FPL5723 1 have been administered, and all reduce the degree of elevated PVR by both reducing Ppa and improving CO. The cyclooxygenase inhibitor, indomethacin, and the thromboxane synthetase inhibitor, dazmegrel, completely reversed the elevation in Ppa (17, (21) (22) (23) . Epinephrine and FPL5723 1 reduced Ppa by only 20 and 35%, respectively (21, 22) . All of these agents improved CO during sepsis but did so to a variable degree. However, in all studies, CO never returned to normal despite treatment.
U46,6 19 infusion in this study produced the same hemodynamic changes that occur during low dose group B streptococcal infusion in piglets. A dose of U46,619 was administered that would double Ppa without producing systemic hypotension or metabolic acidosis in order to avoid these confounding events. Respiratory alkalosis reversed elevated Ppa more effectively than epinephrine or FFL5723 1 but less effectively than indomethacin or dazmegrel. Respiratory alkalosis was as ineffective as epinephrine and much less effective than FPL57231, dazmegrel, or indomethacin in improving the thromboxane-induced reduction in cardiac output. These findings suggest that hemodynamic abnormalities associated with increased thromboxane A2 production may be better treated with specific inhibitors of thromboxane synthetase rather than hyperventilation or catecholamine therapy.
Clinical diseases, such as group B streptococcal sepsis and some forms of persistent pulmonary hypertension of the newborn in the absence of sepsis, are associated with elevated levels of serum thromboxane B2 levels (10) . Both entities are associated with right-to-left shunting of mixed venous blood through the patent ductus and/or the foramen ovale, producing profound hypoxemia unresponsive to assisted ventilation with 100% oxygen (6) . Although hyperventilation therapy to produce respiratory alkalosis has proven an effective therapy for pulmonary hypertension in most of these patients, not all children improve (7. 8) .
Our results may in part explain this experience. Although hyperventilation attenuated the effects of U46,619, PVR remained twice the value measured before infusion of the drug, suggesting incomplete reversal of thromboxane-induced pulmonary vasoconstriction (Tables 1 and 2 ). If pulmonary vasoconstriction in infants with some forms of PPHN does indeed result form increased synthesis of thromboxane A2, then respiratory alkalosis should reduce PVR relative to SVR and reduce rightto-left shunting through the patent ductus arteriosus. However, shunting of venous blood through the foramen ovale will result when right atrial pressure is greater than left atrial pressure. Right atrial pressure is determined in part by right ventricular enddiastolic pressure which in turn is determined by both right ventricular compliance and right ventricular afterload (24) . The persistent reduction in CO and calculated stroke volume during infusion of U46,6 19 despite additional hyperventilation in young piglets, suggests that right ventricular compliance may have been primarily reduced by the thromboxane mimetic independent of PVR. In the newborn with a patent foramen ovale and elevated thromboxane production, right-to-left shunting of blood through the foramen due to increased right atrial pressures and to abnormal right ventricular compliance characteristics would not be necessarily influenced by respiratory alkalosis. Two-wk-old piglets do not have foramenal right-to-left shunting during hypoxia and U46,6 19 infusions based upon dye dilution CO curve profiles. Furthermore, right atrial pressure was not measured in this study. Studies evaluating pulmonary hemodynamics and right heart function in younger animals, i.e. newborns with patent foramen ovales, during states of elevated thromboxane synthesis are warranted to corroborate this speculation and more closely relate experimental findings to clinical management of human neonates.
The results demonstrate that pulmonary vasoconstriction due to stimuli other than hypoxia is partially attenuated by respiratory alkalosis. Nonetheless, clinical entities associated with pulmonary hypertension and elevated serum levels of thromboxane may be accompanied by abnormal cardiac function which might be more consistently improved with therapeutic modalities other than respiratory alkalosis.
